Screener
10x Genomics, Inc. TXG Retained Earnings
Retained Earnings at other companies
Other financials
Where this comes from
Reported directly by 10x Genomics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RetainedEarningsAccumulatedDeficit.
The source filing: 10x Genomics, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 6, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054491
FAQ
- What is 10x Genomics, Inc.'s retained earnings?
- 10x Genomics, Inc. (TXG) reported retained earnings of -$1.54B in Q2 2026.
- How has 10x Genomics, Inc.'s retained earnings changed year-over-year?
- 10x Genomics, Inc.'s retained earnings decreased by 5.1% year-over-year, from -$1.47B to -$1.54B.
- What is the long-term trend for 10x Genomics, Inc.'s retained earnings?
- Over 5 years (2020 to 2025), 10x Genomics, Inc.'s retained earnings has grown at a 13.4% compound annual growth rate (CAGR), from -$805.1M to -$1.51B.
- What does retained earnings mean?
- Cumulative net income earned since inception minus all dividends paid — the total profits reinvested in the business over its lifetime.
Ask your AI about 10x Genomics, Inc.'s retained earnings.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude